Literature DB >> 2803324

A new and highly sensitive immunohistologic diagnostic criterion for Sjögren's syndrome.

P C de Wilde1, L Kater, J P Baak, J C van Houwelingen, R J Hené, P J Slootweg.   

Abstract

Immunohistologic investigation of the sublabial salivary glands of 65 surgical patients who were free of systemic disease (control) and 19 patients with Sjögren's syndrome resulted in a new diagnostic criterion for SS that was more disease-specific than the widely used lymphocytic focus score criterion. Our bivariate classification criterion, which is based on the percentages of IgA- and IgG-containing plasma cells, has a specificity of 95.4% and a sensitivity of 100%, while its overall percentage of misclassification is 3.6%. This immunohistologic diagnostic criterion results in a reduction of the percentage of false-positive diagnoses from 9% to 4.6%.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2803324     DOI: 10.1002/anr.1780321005

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

1.  Monotypic plasma cells in labial salivary glands of patients with Sjögren's syndrome: prognosticator for systemic lymphoproliferative disease.

Authors:  C Bodeutsch; P C de Wilde; L Kater; F H van den Hoogen; R J Hené; J C van Houwelingen; L B van de Putte; G P Vooijs
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

2.  Phlegmonous gastritis: an unusual presenting symptom of Sjögren's syndrome.

Authors:  M L van Leeuwen; H L Tjiong; M van Blankenstein; A H Mulder; C M Bakker
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

3.  The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.

Authors:  C Vitali; H M Moutsopoulos; S Bombardieri
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

Review 4.  Know your enemy or find your friend?-Induction of IgA at mucosal surfaces.

Authors:  Mats Bemark; Davide Angeletti
Journal:  Immunol Rev       Date:  2021-07-30       Impact factor: 10.983

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.